Once monthly injectables to become future therapeutic options for obesity: Report
The report by GlobalData, a data and analytics company, showed that anti-obesity medications are the industry trend that will ...
pharmaphorum4 年
CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar
Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.
Yahoo Finance1 个月
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of ...
Second, Amneal has received approval from the FDA for exenatide, which is the Company’s first generic injectable glucagon-like peptide-1 (GLP-1) agonist and reflects its innovation capabilities ...
来自MSN1 个月
Goodbye Injections? What to Know About the Weight Loss Pills on the Horizon
Popular weight management drugs like Ozempic only come in injectable form ... companies are working to create a pill version of a glucagon-like peptide 1 (GLP-1) receptor agonist, which would ...
来自MSN4 个月
European shortages of Novo Nordisk's Ozempic to continue through Q4
I nvesting.com -- The European market is facing shortages of Novo Nordisk's (NYSE:NVO) injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA), Ozempic, a critical medication for managing ...
Outsourcing-pharma8 天
Verdiva Bio launches with $411m in funding to advance obesity drugs
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...
pharmaphorum6 天
After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome
The company is still digging for efficacy signals among subpopulations in the CedLara trial, but has switched its attention to vurolenatide, an injectable glucagon-like peptide-2 (GLP-2 ...